ROUNDHILL GLP-1 & WGT LS ETF (OZEM:NASDAQ)
$33.12 -0.2749 (-0.8232%)
Analysed ROUNDHILL GLP-1 & WGT LS ETF (OZEM:NASDAQ) News Sources
2 under-the-radar ETFs retail investors should jump on
07-01-2026
yahoo.com
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All
19-01-2026
marketbeat.com
Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook
04-02-2026
yahoo.com
FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFs
23-03-2026
yahoo.com
3 Ways to Invest in the Growing GLP-1 Weight Loss Market
17-04-2026
marketbeat.com
Scoring 2 Million Prescriptions, Novo’s GLP-1 Pill Crushes Expectations
07-05-2026
thedailyupside.com
GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain
19-05-2026
yahoo.com
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
10-06-2026
yahoo.com
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
20-06-2026
marketbeat.com
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage
01-07-2026
yahoo.com
What is the current price of ROUNDHILL GLP-1 & WGT LS ETF (OZEM:NASDAQ)?
The current price of ROUNDHILL GLP-1 & WGT LS ETF (OZEM:NASDAQ) is $33.12.
ROUNDHILL GLP-1 & WGT LS ETF (OZEM:NASDAQ) absolute price change since previous trading day?
The absolute price change of ROUNDHILL GLP-1 & WGT LS ETF (OZEM:NASDAQ) since the previous trading day is $-0.2749.
ROUNDHILL GLP-1 & WGT LS ETF (OZEM:NASDAQ) percentage price change since previous trading day?
The percentage price change of ROUNDHILL GLP-1 & WGT LS ETF (OZEM:NASDAQ) since the previous trading day is -0.8232%.
What is the most recent average sentiment score for ROUNDHILL GLP-1 & WGT LS ETF (OZEM:NASDAQ)?
The most recent average sentiment score for ROUNDHILL GLP-1 & WGT LS ETF (OZEM:NASDAQ) is 63 out of 100.
What is the most recent average sentiment for ROUNDHILL GLP-1 & WGT LS ETF (OZEM:NASDAQ)?
The most recent sentiment for ROUNDHILL GLP-1 & WGT LS ETF (OZEM:NASDAQ) is .
SEC-8K** Filing Available For ROUNDHILL GLP-1 & WGT LS ETF (OZEM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.